Edwards Lifesciences Corporation News
Cramer's Mad Money Recap 5/2: Coca-Cola, American Express, Visa
Investors can't wait for inflation to be broken before they buy.
Cramer's Mad Money Recap 2/1: Colgate-Palmolive, Stanley Black & Decker
Jim Cramer says stocks are caught between the forces of inflation and deflation, and investors need to find companies that can adapt.
Cramer's Mad Money Recap 12/8: Pfizer, Sweetgreen, Edwards Lifesciences
Jim Cramer reminds us the Dow has soared from 1,000 to 35,000 over the course of his career. That's quite a run, despite all the investor negativity.
'Mad Money' Lightning Round: Snap, Boston Scientific
Jim Cramer’s bullish on Snap, Boston Scientific and Cleveland-Cliffs.
Edward Lifesciences Hits Record High After Earnings Beat, TAVR Forecast
Edwards Lifesciences said its sees transcatheter aortic valve replacement (TAVR) sales rising as high as 20% this year.
Reopening Plays: Cramer's 'Mad Money' Recap (Monday 3/1/21)
Jim Cramers sifts through this relentless run in the reopening plays to find the less-obvious companies poised for profit.
Don't Bet Against the Bulls: Cramer's 'Mad Money' Recap (Thursday 12/10/20)
Despite the IPO euphoria, the backdrop to this market is just too optimistic to bet against the bulls, Jim Cramer says.
Vaccine Hopes: Cramer's 'Mad Money' Recap (Wednesday 7/15/20)
Jim Cramer says the markets are optimistic about a vaccine, but he cautions there’s a long way to go. We still need more stimulus.
Tesla Stock Higher As Investors Look Past July China Sales Slump
Tesla sold just over 28,000 China-made cars last month, an industry lobby group said Tuesday.
Novavax Stock Plummets After Slashing 2022 Vaccine Sales Forecast
"I believe we were late to the market and US vaccination was driven by what was available and shown to work," said Novavax CEO Stanley Erck.
Bed Bath & Beyond Extends Short Squeeze Surge In Meme-Stock Rally Return
Suggestions of a Reddit-fueled short-squeeze have shares in struggling home retailer Bed, Bath & Beyond back on the move Tuesday.
Micron Technology Stock Tumbles On Reduced Q4 Chip Sales Forecast
"In FQ1, bit shipments are now expected to decline sequentially, and we expect significant sequential declines in revenue and margins," Micron said.